Skip to content

Author

Yumei Li

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

HIF-1α-mediated metabolic reprogramming in hypoxia-driven tumor metastasis

Tumor metastasis is a multistep process that requires profound metabolic plasticity to support cancer cell invasion, survival in circulation, colonization of distant organs, and metastatic outgrowth. Hypoxia is a hallmark of solid tumors and a major driver of metastatic progression. As a central transcriptional regulat...

Shu-Lun Shao, Meng-Xin Wang, Ren-Jian Xie et al. · 0 citations
Aug 2026

MYC-driven BYSL overexpression promotes hepatocellular carcinoma by suppressing nucleolar stress and inactivating the RPL5/RPL11-MDM2-p53 pathway.

It is revealed that BYSL acts as a pivotal downstream mediator of MYC-regulated ribosome biogenesis and promotes hepatocellular carcinoma progression, suggesting that BYSL may represent a potential therapeutic target for hepatocellular carcinoma.

Heyuan Zhao, Hui-Ying Liu, Xia Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.